|
CENPBD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.557700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.245690E-02 |
| Normal-vs-Stage2 |
1.281380E-01 |
| Normal-vs-Stage3 |
6.798800E-01 |
| Normal-vs-Stage4 |
3.378200E-01 |
| Stage1-vs-Stage2 |
9.065200E-01 |
| Stage1-vs-Stage3 |
3.788200E-01 |
| Stage1-vs-Stage4 |
8.939800E-01 |
| Stage2-vs-Stage3 |
4.519600E-01 |
| Stage2-vs-Stage4 |
9.703200E-01 |
| Stage3-vs-Stage4 |
5.559800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.200760E-01 |
| Normal-vs-AfricanAmerican |
6.437600E-04 |
| Normal-vs-Asian |
6.673200E-01 |
| Caucasian-vs-AfricanAmerican |
4.335400E-03 |
| Caucasian-vs-Asian |
8.387200E-01 |
| AfricanAmerican-vs-Asian |
6.911800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.861860E-02 |
| Normal-vs-Female |
2.078600E-01 |
| Male-vs-Female |
4.911800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.784400E-02 |
| Normal-vs-Extreme_Weight |
2.556200E-02 |
| Normal-vs-Obese |
2.193600E-01 |
| Normal-vs-Extreme_Obese |
8.014100E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.790000E-01 |
| Normal_Weight-vs-Obese |
3.777400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.412800E-01 |
| Extreme_Weight-vs-Obese |
4.887400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.328000E-01 |
| Obese-vs-Extreme_Obese |
5.497600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.405400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.418960E-01 |
| Normal-vs-Age(61-80Yrs) |
1.571840E-02 |
| Normal-vs-Age(81-100Yrs) |
3.769800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.708400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.581000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.321980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.394400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.231370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.176000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.842400E-02 |
| Normal-VS-Type2 PRCC |
5.696100E-02 |
| Normal-VS-KIRP CIMP |
5.022800E-01 |
| Normal-VS-Unclassified PRCC |
8.495200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.067000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.262200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.631800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.763400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.105380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.819200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.332000E-02 |
| Normal-vs-N1 |
3.986800E-01 |
| Normal-vs-N2 |
6.409000E-04 |
| N0-vs-N1 |
3.738600E-01 |
| N0-vs-N2 |
1.328810E-01 |
| N1-vs-N2 |
5.506300E-02 |
|
|
